clinical predictors of functioning in persons with acquired immunodeficiency syndrome.

NLM AIDSLINE Clinical predictors of functioning in persons with acquired immunodeficiency syndrome. Wilson IB; Cleary PD; Department of Medicine, New England Medical Center
October 30, 1996

Med Care. 1996 Jun;34(6):610-23. Unique Identifier : AIDSLINE To help clinicians better assess and treat functional disabilities in persons with acquired immunodeficiency syndrome (AIDS), the authors estimate empirical relations among biologic and physiologic variables, symptoms, and physical functioning in persons with AIDS. The sample of 305 persons with AIDS for this cross-sectional analysis came from three sites in Boston, Massachusetts: a hospital-based group practice, a human immunodeficiency virus clinic at a city hospital, and a staff-model health maintenance organization. Physical functioning, 10 AIDS-specific symptoms, and mental health were assessed by interview. Clinical diagnoses, comorbidities, health habits such as smoking, laboratory results, and selected medication use were assessed by chart review. Significant predictors of physical functioning P < 0.01, R2 = .58) in a multivariable regression model included energy/fatigue, neurologic symptoms, fever symptoms, a lower hemoglobin level, and current non-pneumonia bacterial infection. Ninety-six percent of the explained variance in physical functioning was accounted for by three symptom complexes: energy/fatigue, neurologic symptoms, and fever symptoms. Significant predictors of energy/fatigue in multivariable models included poorer mental health, lower white blood cell count, longer time since diagnosis, and weight loss (P < 0.01, R2 =.36). Significant predictors of neurologic symptoms included poorer mental health, weight loss, and no zidovudine use (P < 0.001, R2 = .30). Predictors of fever symptoms included poorer mental health, no zidovudine use, weight loss, and history of asthma or chronic obstructive pulmonary disease (P < 0.05, R2 = .25). In conclusion, symptom reports were strong predictors of physical functioning. Poorer mental health and weight loss were correlated consistently with worse symptoms, and not using zidovudine was correlated with worse neurologic and fever symptoms. These variables, and the others the authors identified, may represent mutable determinants of physical functioning in persons with AIDS, and potential targets for specific clinical interventions. Acquired Immunodeficiency Syndrome/PHYSIOPATHOLOGY/PSYCHOLOGY Activities of Daily Living Adolescence Adult Boston Cross-Sectional Studies Disabled/CLASSIFICATION Female Group Practice Health Maintenance Organizations Health Status Indicators Human Male Medical Audit Middle Age Multivariate Analysis Outpatient Clinics, Hospital Predictive Value of Tests Quality of Life Questionnaires/*STANDARDS Regression Analysis Reproducibility of Results Support, U.S. Gov't, P.H.S. JOURNAL ARTICLE MULTICENTER STUDY

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 CALIFORNIA: Over Half of People Living with AIDS in San Francisco Are Aged 50 or Older THAILAND; UNITED STATES: HIV Drug Can Also Protect Injection Drug Users INDONESIA: Growing HIV/AIDS Awareness in Indonesia's Papua Region UNITED STATES: Many Young Americans Unaware They're Infected with HIV Board to Vote on Condoms in Boston Schools New International Report on HIV Prevention Urges Localized Consideration of Antiretroviral Strategies UNAIDS and Lancet to bring together political and health leaders to shape the debate on the future of global health Cambodia Trains Social Workers to Curb Reliance on Foreign Aid New Hampshire nears approval of medical marijuana law Celebrating 10 years of PEPFAR ABL Acquires Evivar Medical Assets and Further Enhances its IT Solutions and Personalized Healthcare Platform for Hepatitis B, Hepatitis C and HIV Infections Survey of Participants from Landmark GRACE Trial Provides Patients' Perspectives from an HIV Clinical Study MARYLAND: People More Likely to Keep HIV Clinic Appointments if They Believe Their Care Providers Know Them as a Person Sangamo BioSciences Presents Clinical Data Demonstrating HIV Reservoir Reduction in HIV-Infected Subjects Treated with ZFP Therapeutic(R), SB-728-T CALIFORNIA: No Link Found Between Vaccines, Guillain-Barre Syndrome CALIFORNIA: No Link Found Between Vaccines, Guillain-Barre Syndrome Ascletis Gains China Market Rights from Janssen to a Clinical Stage HIV Protease Inhibitor Inovio Collaborator ChronTech Reports Interim Phase II Clinical Study Results from ChronVac-C Vaccine for Hepatitis C Infection Clinical Care Options to be the Official Provider of Online Scientific Analysis of the 7th International AIDS Society Conference On HIV Pathogenesis, Treatment and Prevention VGTI Florida Scientists Reveal a Mystery of Diminished Immune Function in HIV Infection
Information in this article was accurate in October 30, 1996. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.